JPS52151168A - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
JPS52151168A
JPS52151168A JP6525277A JP6525277A JPS52151168A JP S52151168 A JPS52151168 A JP S52151168A JP 6525277 A JP6525277 A JP 6525277A JP 6525277 A JP6525277 A JP 6525277A JP S52151168 A JPS52151168 A JP S52151168A
Authority
JP
Japan
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6525277A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6222986B2 (es
Inventor
Goodon Karudoueru Arubaato
Uitsutoteikaa Nooman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS52151168A publication Critical patent/JPS52151168A/ja
Publication of JPS6222986B2 publication Critical patent/JPS6222986B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP6525277A 1976-06-03 1977-06-02 Heterocyclic compound Granted JPS52151168A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB5034076 1976-12-02
GB1214577 1977-03-23

Publications (2)

Publication Number Publication Date
JPS52151168A true JPS52151168A (en) 1977-12-15
JPS6222986B2 JPS6222986B2 (es) 1987-05-20

Family

ID=27256793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6525277A Granted JPS52151168A (en) 1976-06-03 1977-06-02 Heterocyclic compound

Country Status (12)

Country Link
JP (1) JPS52151168A (es)
CA (1) CA1176261A (es)
CH (3) CH645631A5 (es)
DE (1) DE2724948A1 (es)
DK (1) DK244577A (es)
ES (5) ES459412A1 (es)
FI (1) FI71930C (es)
FR (1) FR2362839A1 (es)
HU (1) HU183046B (es)
NL (1) NL7706064A (es)
NZ (1) NZ184281A (es)
SE (2) SE446336B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006527189A (ja) * 2003-06-06 2006-11-30 アラーガン、インコーポレイテッド ピペリジニルプロスタグランジンｅ類似体
JP2011173926A (ja) * 2003-06-06 2011-09-08 Allergan Inc ピペリジニルプロスタグランジンｅ類似体

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
AU527959B2 (en) * 1977-09-05 1983-03-31 Wellcome Foundation Limited, The Hydantoin derivatives
DK543178A (da) * 1977-12-01 1979-06-02 Wellcome Found Thiodydantoinderivater
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (en) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
EP0007180B1 (en) * 1978-06-15 1983-03-30 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
JPS55151569A (en) * 1979-05-09 1980-11-26 Wellcome Found Optically active heterocyclic compounds* their synthesis and medical blend containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
MXPA04005123A (es) * 2001-11-30 2005-02-17 Lilly Co Eli Agonistas del receptor activado por proliferador de peroxisoma.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006527189A (ja) * 2003-06-06 2006-11-30 アラーガン、インコーポレイテッド ピペリジニルプロスタグランジンｅ類似体
JP2011173926A (ja) * 2003-06-06 2011-09-08 Allergan Inc ピペリジニルプロスタグランジンｅ類似体

Also Published As

Publication number Publication date
ES459412A1 (es) 1978-11-01
FI71930C (fi) 1987-03-09
ES8103057A1 (es) 1981-02-16
ES489883A0 (es) 1981-02-16
CH646426A5 (en) 1984-11-30
NL7706064A (nl) 1977-12-06
HU183046B (en) 1984-04-28
SE7706428L (sv) 1977-12-04
ES470428A1 (es) 1979-09-01
FR2362839B1 (es) 1980-02-01
DK244577A (da) 1977-12-04
DE2724948A1 (de) 1977-12-15
CA1176261A (en) 1984-10-16
CH645631A5 (en) 1984-10-15
NZ184281A (en) 1980-04-28
SE8203161L (sv) 1982-05-19
FR2362839A1 (fr) 1978-03-24
SE446336B (sv) 1986-09-01
ES478156A1 (es) 1979-11-01
JPS6222986B2 (es) 1987-05-20
FI71930B (fi) 1986-11-28
FI771763A (fi) 1977-12-04
CH647511A5 (en) 1985-01-31
ES482010A1 (es) 1980-08-16

Similar Documents

Publication Publication Date Title
EG13149A (en) Heterocyclic compounds
JPS52151348A (en) Compound
ZA771381B (en) Heterocyclic compounds
JPS5363424A (en) Bitumious compound
JPS52151168A (en) Heterocyclic compound
JPS52125197A (en) Transshexahydroopyridooindole compound
ZA771963B (en) Heterocyclic compounds
JPS52136170A (en) Heterocyclic compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5359686A (en) Compound
JPS5325537A (en) Compound
JPS5295689A (en) Betaalactummcontaining compound
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS55127390A (en) Aryltrifluoroethylamine compound
ZA774154B (en) Heterocyclic compounds
JPS5293772A (en) Indolinospiropyran compound
ZA777535B (en) Heterocyclic compounds
JPS5323995A (en) Antiibacterial compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS5315371A (en) Heterocyclic compound
JPS5315383A (en) Heterocyclic compound
JPS5353692A (en) Antiiworm compound
JPS5315370A (en) Heterocyclic compound
JPS55102588A (en) Tetraselenapentalene compound